Cargando…
Remdesivir: the first FDA-approved anti-COVID-19 Treatment for Young Children
Following the emergence of the SARS-CoV-2 pandemic, finding efficient forms of treatment is seen as a priority for both adults and children. On April 25, 2022, remdesivir has become the first United States Food and Drug Administration (FDA) approved COVID-19 treatment for young children, specificall...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Applied Systems srl
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491826/ https://www.ncbi.nlm.nih.gov/pubmed/36156901 http://dx.doi.org/10.15190/d.2022.10 |